Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Want to see HK:2315 full AI Analyst Report?
Comparison Results
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$20.67B
25.33
299.68%
―
Ascletis Pharma, Inc.
HK$18.48
HK$15.76B
-27.65
135.71%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$7.99B
9.33
0.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$17.22B
-8.22
46.77%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.20B
-75.25
-15.24%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.01
HK$3.93B
424.16
-37.92%
―
Performance Comparison
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
50.60
36.32
254.34%
HK:1672
Ascletis Pharma, Inc.
14.85
7.85
112.14%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.43
-0.04
-0.89%
HK:2162
Keymed Biosciences, Inc.
61.35
19.15
45.38%
HK:2171
CARsgen Therapeutics Holdings Ltd.
17.63
-3.97
-18.38%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
6.32
-4.68
-42.55%